You can also search for this author in PubMed                                       Google Scholar                                       Scientis

This malaria vaccine is delivered by a mosquito bite

submited by
Style Pass
2024-11-21 18:00:09

You can also search for this author in PubMed   Google Scholar

Scientists have developed a new vaccination strategy for malaria — boosting immunity through bites from mosquitoes carrying a genetically engineered version of the parasite that causes malaria. In a trial, the approach reduced participants’ susceptibility to malaria, potentially paving the way for more effective ways to stop the disease, which infects some 250 million people a year.

“These findings represent a significant step forward in malaria vaccine development,” says Julius Hafalla, an immunologist at the London School of Hygiene & Tropical Medicine. “The ongoing global malaria burden makes the development of more effective vaccines a critical priority.”

The study, which was published1 in The New England Journal of Medicine on 20 November, exposed participants to bites from mosquitoes that had a modified version of the Plasmodium falciparum parasite, which causes malaria. In humans, the parasites travel to the liver and then infect red blood cells. The parasites were engineered to stop developing shortly after delivery into a human. Nearly 90% of participants exposed to the modified parasites avoided contracting the disease after being bitten by malaria mosquitoes.

Leave a Comment